West Virginia HB4610 allows eligible patients with life-threatening or severely debilitating illnesses to access individualized investigational.

West Virginia HB4610, the Safeguard the Right-To-Try Cutting-Edge Medicine Act, permits patients with life-threatening or severely debilitating illnesses to access individualized investigational treatments. The bill defines "eligible patient" as someone with a life-threatening or severely debilitating illness, who has exhausted all approved treatments, and has given informed consent. It prohibits state officials, health care providers, and manufacturers from blocking access to these treatments and ensures that heirs are not liable for outstanding debt related to the treatment.

West Virginia HB4610 allows eligible patients with life-threatening or severely debilitating illnesses to access individualized investigational.

West Virginia HB4610, the Safeguard the Right-To-Try Cutting-Edge Medicine Act, permits patients with life-threatening or severely debilitating illnesses to access individualized investigational treatments. The bill defines "eligible patient" as someone with a life-threatening or severely debilitating illness, who has exhausted all approved treatments, and has given informed consent. It prohibits state officials, health care providers, and manufacturers from blocking access to these treatments and ensures that heirs are not liable for outstanding debt related to the treatment.